Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

Targeting the CD4+ effector memory T cells re-expressing CD45RA suppressor galectin-7: a multi-omics-guided therapeutic strategy for idiopathic pulmonary fibrosis

Open access

Abstract

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive interstitial lung disease with limited therapeutic options. Although single-cell and spatial transcriptomics have revealed cellular heterogeneity within the IPF lung microenvironment, the immune drivers with causal relevance remain poorly defined. Here, through large-scale Mendelian randomization integrating multi-omics data, we identified a consistent negative causal association between the proportion of CD4⁺ effector memory T cells re-expressing CD45RA (TEMRA) and IPF risk. Multi-platform validation—including single-cell RNA sequencing, flow cytometry, and multiplex immunofluorescence—confirmed a significant reduction in CD4⁺ TEMRA frequency in both peripheral blood and lung tissues of IPF patients, establishing this subset as a clinically relevant biomarker. Spatial transcriptomics further revealed a negative correlation between TEMRA differentiation signatures and local fibrotic burden. Mechanistically, integrated single-cell analyses pinpointed metaplastic KRT5⁺ basal cells as a key epithelial population with the capacity to disrupt immune homeostasis. These aberrant epithelial cells upregulate Galectin-7 ( LGALS7 ), which we demonstrate competes with IL-7 for receptor binding, suppresses STAT5 phosphorylation, and limits CD4⁺ TEMRA differentiation, thereby uncovering a previously unrecognized epithelial–immune crosstalk axis in IPF. Guided by these findings, virtual screening of 20,000 compounds identified neoeriocitrin as a Galectin-7 inhibitor that restores STAT5 phosphorylation in vitro and attenuates pulmonary fibrosis in vivo. This study positions Galectin-7 as a druggable target and establishes a novel framework linking epithelial dysfunction to immune dysregulation in IPF.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s43556-026-00542-0

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 52 references

Cited by

Still being checked.

Metadata

Authors
Yan, T., Liu, J., Liu, Y., Gu, W., Liu, J., Li, Y., Lv, R., Zhang, C., Ding, J., Zha, C., Wang, C., Gao, F., Huang, M., & Chen, J.
Affiliations
  • Chinese Academy of Sciences (CN)
  • Wuxi People's Hospital (CN)
  • Chiba University (JP)
  • Affiliated Hospital of Qingdao University (CN)
  • Second Affiliated Hospital of Zhejiang University (CN)
Corresponding author
  • Wang, Chaoqun
  • Gao, Fei
  • Huang, Man
  • Chen, Jingyu
Venue
Molecular Biomedicine
Published
2026-10-05
Volume
7
Issue
1
ISSN
2662-8651 (ISSN-L)
OpenAlex
W7219680325
Cited by
0
References
52
FWCI
0.00
Type
journal article
Language
en
Open access
Licence
Locations
  • Molecular Biomedicine (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • Noncommunicable Chronic Diseases-National Science and Technology Major Project (2023ZD0505900)
  • National Key Research and Development Program of China (2023YFC2507105)
  • National Natural Science Foundation of China (82370070)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
  • Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
Keywords
idiopathic pulmonary fibrosis, CD4+ effector memory T cells, TEMRA cells, CD45RA, galectin-7, STAT5 phosphorylation, epithelial-immune crosstalk, neoeriocitrin, therapeutic target, pulmonary fibrosis, immune dysregulation, Mendelian randomization, biomarkers
MeSH terms
Memory T Cells, Multiomics, Animals, Humans, Immunologic Memory, CD4-Positive T-Lymphocytes, Leukocyte Common Antigens, Galectins, STAT5 Transcription Factor, Mice, Idiopathic Pulmonary Fibrosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Targeting the CD4+ effector memory T cells re-expressing CD45RA suppressor galectin-7: a multi-omics-guided therapeutic strategy for idiopathic pulmonary fibrosis. https://app.cochat.ai/papers/10.1186/s43556-026-00542-0
The paper
Yan, T., Liu, J., Liu, Y., Gu, W., Liu, J., Li, Y., Lv, R., Zhang, C., Ding, J., Zha, C., Wang, C., Gao, F., Huang, M., & Chen, J. (2026). Targeting the CD4+ effector memory T cells re-expressing CD45RA suppressor galectin-7: a multi-omics-guided therapeutic strategy for idiopathic pulmonary fibrosis. Molecular Biomedicine. https://doi.org/10.1186/s43556-026-00542-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.